サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1328646

バイオ医薬品バイオセパレーションシステムの世界市場

Biopharmaceutical Bioseparation Systems
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 360 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
バイオ医薬品バイオセパレーションシステムの世界市場
出版日: 2023年08月15日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 360 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

バイオ医薬品バイオセパレーションシステムの世界市場は2030年までに313億米ドルに達する

COVID-19後の変化したビジネス環境において、2022年に130億米ドルと推定されたバイオ医薬品バイオセパレーションシステムの世界市場は、2030年までに313億米ドルの市場規模に改定され、2022年から2030年にかけてCAGR 11.6%で成長すると予測されます。本レポートで分析したセグメントの1つであるクロマトグラフィは、CAGR 10.9%を記録し、分析期間終了時には152億米ドルに達すると予測されています。現在進行中のパンデミック後の回復を考慮し、その他の技術分野の成長は今後8年間のCAGRを12.3％に修正しました。

米国市場は57億米ドル、中国はCAGR14.3％で成長すると予測

米国のバイオ医薬品バイオセパレーションシステム市場は、2022年には57億米ドルになると推定されます。世界第2位の経済大国である中国は、2022年から2030年までの分析期間においてCAGR14.3%で推移し、2030年までに39億米ドルの市場規模に達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ9.6%と10%の成長が予測されています。欧州では、ドイツがCAGR約10.5%で成長すると予測されています。

調査対象企業の例

  • 3M Company
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Alfa Laval AB
  • GEA Group AG
  • AMS Biotechnology（Europe）Ltd.（amsbio）
  • Biotage AB
  • AnteoTech
  • BIA Separations d.o.o.
  • Heinkel Drying and Separation Group
  • 3B Pharmaceuticals GmbH
  • Critical Process Filtration, Inc.
  • Flottweg SE
  • Ellutia
  • Global Life Sciences Solutions USA LLC（Cytiva）

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-7973

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Biopharmaceutical Bioseparation Systems Market to Reach $31.3 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Biopharmaceutical Bioseparation Systems estimated at US$13 Billion in the year 2022, is projected to reach a revised size of US$31.3 Billion by 2030, growing at aCAGR of 11.6% over the period 2022-2030. Chromatography, one of the segments analyzed in the report, is projected to record 10.9% CAGR and reach US$15.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Other Technologies segment is readjusted to a revised 12.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $5.7 Billion, While China is Forecast to Grow at 14.3% CAGR

The Biopharmaceutical Bioseparation Systems market in the U.S. is estimated at US$5.7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.9 Billion by the year 2030 trailing a CAGR of 14.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.6% and 10% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.5% CAGR.

Select Competitors (Total 61 Featured) -

  • 3M Company
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Alfa Laval AB
  • GEA Group AG
  • AMS Biotechnology (Europe) Ltd. (amsbio)
  • Biotage AB
  • AnteoTech
  • BIA Separations d.o.o.
  • Heinkel Drying and Separation Group
  • 3B Pharmaceuticals GmbH
  • Critical Process Filtration, Inc.
  • Flottweg SE
  • Ellutia
  • Global Life Sciences Solutions USA LLC (Cytiva)

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • How the Healthcare Industry Has & Continues to be Impacted by the Pandemic & What's the New Normal?
    • With the COVID-19 Pandemic Exposing Global Healthcare Unpreparedness, There is Increasing Policy Led Focus on Rebooting Health Systems Worldwide: Current & Required Healthcare Spending as % of GDP
    • Year 2021 in Review and Near-term Outlook
    • Prolonged Pandemic, Ukraine-Russia Conflict and Ensuing Economic Disruptions Impact Growth Outlook
    • World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2021, 2022 and 2023
    • Impact of COVID-19 on Biopharmaceutical Bioseparation Market
    • Scope of Affinity Chromatography in Aiding the Vaccine Purification methodology
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Biopharmaceutical Bioseparation Systems - Global Key Competitors Percentage Market Share in 2022 (E)
    • Biopharmaceutical Bioseparation Systems Competitor Market Share Scenario Worldwide (in %): 2020E
    • A Prelude to Biopharmaceutical Bioseparation Systems
    • A Peek into Biopharmaceutical Manufacturing
    • Downstream Processing of Biosynthetic Products - An Overview
    • Bioseparation Systems - Invaluable Tools in Biopharmaceutical Manufacturing
    • US Remains Market Leader; Developing Countries to Drive Market Growth
    • Chromatography Leads the Pack
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Biopharmaceutical Market Drives Demand for Bioseparation Systems
    • Top 10 Biopharmaceutical Companies: 2020
    • Biological License Application (BLA) Approvals - 2022
    • Biological License Application (BLA) Approvals-2021
    • Biological License Application (BLA) Approvals-2020
    • Biological License Application (BLA) Approvals: 2019
    • Targeted Therapies Gain Momentum, Cancer Immunotherapies on the Rise
    • Process Intensification Aids in Greater Productivity
    • Evolution of Chromatography Applications for the Biopharmaceutical Sector
    • Chromatography in Cell & Gene Therapies
    • Chromatography Methods Fraught with Issues
    • Growing Biosimilars Market - A Clear Advantage for Bioseparation Technologies
    • Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe
    • Progressive Regulatory Framework Accelerates Product Approvals & Subsequently Market Revenues
    • Specific Guidelines for Biosimilars in Various Countries with Year of Publication
    • Biosimilars Regulatory Agencies in Select Regional Markets
    • Biosimilar Approvals in the US (as of April 2022)
    • Biosimilar Approvals in Europe (as of April 2022)
    • High Demand for Monoclonal Antibodies Generates Significant Opportunities for Bioseparation Systems
    • Downstream Processing - A Major Trend among Biopharmaceutical Manufacturers
    • Chromatography - The Gold Standard Separation Technology
    • Global Chromatography Market (2021): Percentage Share Breakdown of Value Sales by Chromatography Techniques for Gas Chromatography, Liquid Chromatography, Supercritical Fluid Chromatography, Thin Layer Chromatography, and Others
    • Increasing Demand for Gas Chromatography in Biopharma Separation
    • Superior Efficiency Drives Use of Synthetic Ligands in Affinity Chromatography
    • A Comparison of Protein and Synthetic Ligands
    • Pre-packed Disposable Columns in Chromatography Gain Attention
    • SMBC - An Old Approach Gaining Significant Attention
    • Major Advantages and Disadvantages of SMBC
    • Twin-Column SMB - An Emerging Alternative to Protein A Columns
    • Growing Focus on Alternatives to Protein A Chromatography
    • Chiral Chromatography Increases in Popularity
    • Chromatography Efficiency and Selectivity
    • Mixed-Mode Chromatography
    • Multimode Chromatography
    • Mixed-Mode and Multimode Media Offer Cost Savings
    • Flexible and Selective Chromatography Improves Biopharmaceutical Efficiencies
    • Inherent Benefits of Membrane Chromatography to Drive its Use in Bioprocessing
    • His-tagged purification of protein & Immobilized Metal Affinity Chromatography (IMAC)
    • Growing Use of Membrane Filtration in Biopharmaceutical Manufacturing
    • Downstream Production of Biopharmaceuticals: Filtration Challenges
    • Evolving Membrane Functions in Filtration for the Production of mAbs
    • Filtration Technology: The Future
    • Membrane Adsorbers Gain Ground in Biopharmaceutical Downstream Purification
    • Prospering Vaccine Market Drives Use of Ultrafiltration Techniques
    • Membrane & Bioseparation
    • Need for Highly Efficient Membranes Rises
    • Downstream Response of Industry to Upstream Scale-Up
    • Hand-powered Centrifuge setup can Diagnose Covid-19 for just a dollar a test
    • Cell Disruption & Methods Gain Popularity
    • Advent of Innovative Technologies Streamline and Enhance Production of Biopharmaceutical Systems
    • Affinity Technologies Improve Productivity
    • Nanofiber Chromatography Technology Advantageous
    • Convective Media Set to Gain Growing Use
    • Nanotechnology Set to Add Interesting Dimension to Biological Separation
    • Rise of Magnetic Nanoparticles
    • Magnetic Biological Separation: Key Steps
    • Why Carbon Nanotubes are Gaining Attention
    • Application of Nanoporous & Nanofiber Membranes
    • Key Challenges & the Road Ahead
    • Continuous Bioprocessing Holds Potential to Positively Impact Biomanufacturing
    • Perfusion Gains Attention
    • Use of Continuous Purification on the Rise in Viral Processes
    • Introduction of Integrated Continuous Bioprocessing System Improves Productivity and Minimizes Raw Material Wastage
    • Use of Continuous Processing Technique for Manufacturing Life-Saving Medicines Gains Momentum
    • Demand for Sustainable Nanofiber Chromatography Mechanism Witnesses an Upward Momentum
    • Use of Precipitation Technique for Purifying Therapeutic Proteins Exhibits a Surge
    • Continuous Bioseparation Gains Momentum
    • Single-Use Systems Play a Key Role
    • Minimizing Centrifugation Steps
    • Single-Use Disposable Technologies Gain Attention
    • Innovative Approaches to Overcome Perennial & Existing Challenges with Process Chromatography
    • Increase in Healthcare Spending Stirs Demand for Biopharmaceutical Bioseperation Systems
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Growing Preference for Personalized Medicine to Drive Market Growth
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biopharmaceutical Bioseparation Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 4: World 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 7: World 16-Year Perspective for Chromatography by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 10: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Market Facts & Figures
    • Market Analytics
    • TABLE 11: USA Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • JAPAN
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • CHINA
    • TABLE 20: China Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 22: China 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • EUROPE
    • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • FRANCE
    • TABLE 29: France Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: France 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • GERMANY
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • TABLE 38: UK Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • INDIA
    • TABLE 59: India Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: India 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • MIDDLE EAST
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030
  • AFRICA
    • TABLE 89: Africa Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Africa Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Africa 16-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2014, 2023 & 2030

IV. COMPETITION